2023
DOI: 10.3389/fgene.2023.1199087
|View full text |Cite
|
Sign up to set email alerts
|

A review of multi-omics data integration through deep learning approaches for disease diagnosis, prognosis, and treatment

Abstract: Accurate diagnosis is the key to providing prompt and explicit treatment and disease management. The recognized biological method for the molecular diagnosis of infectious pathogens is polymerase chain reaction (PCR). Recently, deep learning approaches are playing a vital role in accurately identifying disease-related genes for diagnosis, prognosis, and treatment. The models reduce the time and cost used by wet-lab experimental procedures. Consequently, sophisticated computational approaches have been develope… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 83 publications
0
2
0
Order By: Relevance
“…Robust feature selection, regularization techniques, and validation strategies are required to mitigate overfitting and improve the generalizability of radiomics models [15,22]. Recent advances in radiomics have focused on addressing its limitations and harnessing its full potential through innovative approaches and technologies such as multi-modal radiomics, deep learning approaches, and integration with genomics and proteomics [24,25]. However, the suboptimal quality in reporting current radiomics studies, as assessed based on the RQS by studies, suggests a generally low standard, with an overall average score of approximately 50% [15].…”
Section: Advantages and Challenges Of Radiomics In Cancer Detectionmentioning
confidence: 99%
“…Robust feature selection, regularization techniques, and validation strategies are required to mitigate overfitting and improve the generalizability of radiomics models [15,22]. Recent advances in radiomics have focused on addressing its limitations and harnessing its full potential through innovative approaches and technologies such as multi-modal radiomics, deep learning approaches, and integration with genomics and proteomics [24,25]. However, the suboptimal quality in reporting current radiomics studies, as assessed based on the RQS by studies, suggests a generally low standard, with an overall average score of approximately 50% [15].…”
Section: Advantages and Challenges Of Radiomics In Cancer Detectionmentioning
confidence: 99%
“…In Table 2 , a comprehensive analysis of the scope of review articles indicates that existing studies can be classified into three distinct groups. (I) Nine review papers primarily focus on the application of DL algorithms in survival prediction (Ahmed, 2005 ; Bakasa and Viriri, 2021 ; Kvamme and Borgan, 2021 ; Pobar et al, 2021 ; Kantidakis et al, 2022 ; Altuhaifa et al, 2023 ; Salerno and Li, 2023 ; Wekesa and Kimwele, 2023 ; Wiegrebe et al, 2023 ), (II) seven review papers summarize the application of ML algorithms in survival prediction (Gupta et al, 2018 ; Lee and Lim, 2019 ; Boshier et al, 2022 ; Guan et al, 2022 ; Mo et al, 2022 ; Wissel et al, 2022 ; Feldner-Busztin et al, 2023 ), andsix review papers summarize survival prediction methods from three different categories namely statistical, ML, and DL methods (Bashiri et al, 2017 ; Herrmann et al, 2021 ; Tewarie et al, 2021 ; Westerlund et al, 2021 ; Deepa and Gunavathi, 2022 ; Rahimi et al, 2023 ).…”
Section: A Look-back Into Existing Review Studiesmentioning
confidence: 99%
“…The advent of deep learning technologies has revolutionized the analysis of multi-omics data, particularly in complex disorders such as cancer and neurodegenerative diseases. Deep Neural Networks (DNNs) and Graph Neural Networks (GNNs), with their ability to capture complex patterns across multiple layers of information, have proven instrumental in identifying novel biomarkers, deciphering cancer progression, and predicting responses to therapies [5][6][7][8] . This has opened new avenues for understanding tumor biology and has been a catalyst in the movement toward personalized and precise cancer treatments [9][10][11] .…”
Section: Introductionmentioning
confidence: 99%